Veradermics

MANENYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.779 B

$114.39 +5.28%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$70.0M

Loss-making

Shares outstanding

37,340,290

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#60Dyne TherapeuticsDYN$4.90B
#61Indivior PharmaceuticalsINDV$4.84B
#62VeradermicsMANE$4.78B
#63Edgewise TherapeuticsEWTX$4.68B
#64Enliven TherapeuticsELVN$4.43B

Where these numbers come from

Share counts and financials for Veradermics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.